DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, offering promising progress throughout several health care and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, much more reputable choice for therapeutic use, specially in